- Home
- WRN vs TKNO Comparison
WRN vs TKNO Comparison
Compare WRN & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WRN | TKNO |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.2M | 268.1M |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WRN | TKNO |
|---|---|---|
| Price | $2.35 | $9.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.58 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 193.1K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | N/A | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $1.83 | $1.91 |
| 52 Week High | $4.26 | $9.35 |
Technical Indicators
Market Signals| Indicator | WRN | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 47.74 | 73.40 |
| Support Level | $2.26 | $4.87 |
| Resistance Level | $2.61 | N/A |
| Average True Range (ATR) | 0.11 | 0.47 |
| MACD | -0.01 | 0.17 |
| Stochastic Oscillator | 40.26 | 80.13 |
Price Performance
Historical ComparisonAbout WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project). The Casino can deliver the critical minerals necessary for the energy transition while serving as an engine for long-term economic growth and prosperity in the North.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.